Status:

COMPLETED

Minimal Stimulation or Clomiphene Citrate in Treatment of Polycystic Ovary Syndrome

Lead Sponsor:

Mansoura University

Conditions:

Polycystic Ovary Syndrome

Eligibility:

FEMALE

20-39 years

Phase:

NA

Brief Summary

The purpose of this study is to compare and determine the the efficacy of minimal stimulation and clomiphene citrate(CC) as the first-line treatment in infertile women with Polycystic Ovary Syndrome(P...

Detailed Description

All patients received 100 mg CC (Clomid®; Global Napi Pharmaceuticals, Cairo, Egypt) for 5 days starting from day 3 of spontaneous or induced menstruation. In group A (minimal stimulation), 2 vials of...

Eligibility Criteria

Inclusion

  • PCOS
  • No other infertility factors
  • No previous use of ovarian stimulation drugs

Exclusion

  • Congenital adrenal hyperplasia
  • Cushing syndrome
  • Androgen secreting tumors

Key Trial Info

Start Date :

August 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2010

Estimated Enrollment :

113 Patients enrolled

Trial Details

Trial ID

NCT01157312

Start Date

August 1 2008

End Date

April 1 2010

Last Update

July 19 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Mansoura University Hospitals,OB/GYN department

Al Mansurah, Dakahlia Governorate, Egypt

Minimal Stimulation or Clomiphene Citrate in Treatment of Polycystic Ovary Syndrome | DecenTrialz